# OnCo record surgery-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/roadmaps/surgery-roadmap/>
  a schema:CreativeWork ;
  onco:kind "roadmap" ;
  schema:identifier "surgery-roadmap" ;
  schema:name "Surgery roadmap: radical operations → less surgery → no surgery when a drug has done the work"@en ;
  schema:description "Surgery cures more cancers than any other treatment. Its story for a century has been learning how much can safely be left in, and now whether the operation is needed at all once drugs and radiation have cleared the tumour."@en ;
  schema:url <https://onco.cc/roadmaps/surgery-roadmap/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.nejm.org/doi/full/10.1056/NEJMoa1613210>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2400634>, <https://www.thelancet.com/commissions/global-cancer-surgery> ;
  onco:related <https://onco.cc/ideas/idea-bio2-prehabilitation-standard/>, <https://onco.cc/ideas/idea-acc-geriatric-co-management-surgery/>, <https://onco.cc/ideas/idea-acc-prehabilitation-older-surgery/>, <https://onco.cc/ideas/idea-tr1-window-of-opportunity-default/>, <https://onco.cc/ideas/idea-tr2-neoadjuvant-combo-platform/>, <https://onco.cc/ideas/idea-prev-opportunistic-salpingectomy-default/>, <https://onco.cc/ideas/idea-prev-small-renal-mass-surveillance/>, <https://onco.cc/ideas/idea-bio2-neoadjuvant-biomarker-engine/>, <https://onco.cc/companies/oxford-nanopore/>, <https://onco.cc/companies/histosonics/>, <https://onco.cc/roadmaps/cure-paths/>, <https://onco.cc/roadmaps/devices-roadmap/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:sections <https://onco.cc/fronts/surgery/> ;
  onco:technologies <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/fluorescence-guided-surgery/>, <https://onco.cc/technologies/optical-imaging/>, <https://onco.cc/technologies/thermal-ablation/>, <https://onco.cc/technologies/irreversible-electroporation/>, <https://onco.cc/technologies/hifu-histotripsy/>, <https://onco.cc/technologies/tace/>, <https://onco.cc/technologies/radioembolisation-tare/>, <https://onco.cc/technologies/hipec/>, <https://onco.cc/technologies/endoscopic-resection/>, <https://onco.cc/technologies/tors/>, <https://onco.cc/technologies/robotic-bronchoscopy/>, <https://onco.cc/technologies/liver-transplant-oncology/>, <https://onco.cc/technologies/partial-nephrectomy-active-surveillance/>, <https://onco.cc/technologies/prehabilitation/>, <https://onco.cc/technologies/eras-perioperative-nutrition/>, <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/limb-salvage-surgery/>, <https://onco.cc/technologies/intraoperative-radiotherapy/> ;
  onco:trials <https://onco.cc/trials/mslt-ii/>, <https://onco.cc/trials/lacc/>, <https://onco.cc/trials/fires-sentor/>, <https://onco.cc/trials/senticol-iii/>, <https://onco.cc/trials/checkmate-816/>, <https://onco.cc/trials/keynote-671/>, <https://onco.cc/trials/nadina/>, <https://onco.cc/trials/swog-s1801/>, <https://onco.cc/trials/matterhorn/>, <https://onco.cc/trials/niagara/>, <https://onco.cc/trials/keynote-522/>, <https://onco.cc/trials/destiny-breast11/>, <https://onco.cc/trials/niche-2/>, <https://onco.cc/trials/azur-1/>, <https://onco.cc/trials/sano/>, <https://onco.cc/trials/mars-2/>, <https://onco.cc/trials/estimabl2/>, <https://onco.cc/trials/ovhipec-1/>, <https://onco.cc/trials/emerald-1/>, <https://onco.cc/trials/prehab-trial/>, <https://onco.cc/trials/elective-neck-dissection-tmh/>, <https://onco.cc/trials/preopanc/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-surgery-radiation-innovation/>, <https://onco.cc/bottlenecks/b-workforce/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-aging-comorbidity/> .